0001751912 2026-05-26 2026-05-26 0001751912 1 2026-05-26 2026-05-26 0001751912 2 2026-05-26 2026-05-26 0001751912 3 2026-05-26 2026-05-26 0001751912 4 2026-05-26 2026-05-26 0001751912 5 2026-05-26 2026-05-26 0001751912 6 2026-05-26 2026-05-26 0001751912 1 2026-05-26 2026-05-26 0001751912 2 2026-05-26 2026-05-26 iso4217:USD pure F-10 F-10 EX-FILING FEES 0001751912 NERVGEN PHARMA CORP. N/A 0.0001381 0.0001381 0.0001381 0.0001381 0.0001381 true false F-10 NERVGEN PHARMA CORP. Equity Common shares, no par value true Debt Debt Securities true Other Subscription receipts true Other Warrants true Other Units true false Unallocated (Universal) Shelf true 250000000.00 0.0001381 34525.00 250000000.00 34525.00 0.00 12429.00 22096.00 There are being registered under this Registration Statement such indeterminate number of common shares, debt securities, subscription receipts, warrants and units contracts of NervGen Pharma Corp. (the "Registrant") as shall have an aggregate initial offering price not to exceed US$250,000,000. The proposed maximum initial offering price per security will be determined, from time to time, by the Registrant in connection with the sale of the securities under this Registration Statement. The proposed maximum aggregate offering price per unit of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. The proposed maximum aggregate offering price per class of security will be determined from time to time by the registrant in connection with the issuance by the registrant of the securities registered hereunder and is not specified as to each class of security. true NervGen Pharma Corp. F-10 333-292197 2025-12-17 12429.00 Unallocated (Universal) Shelf 90000000.00 true NervGen Pharma Corp F-10 333-292197 2025-12-17 20715.00 An aggregate registration fee of U.S.$20,715 was previously paid in connection with $150,000,000 of securities registered under the Registration Statement on Form F-10 (File No. 333-292197) (the "Prior Registration Statement") initially filed on December 17, 2025 by the Registrant, including U.S.$12,429.00 paid in relation to $90,000,000 of securities remaining unsold in the offering contemplated by the Prior Registration Statement, which unsold securities are hereby deregistered. Consequently, pursuant to Rule 457(p) of the U.S. Securities Act of 1933, as amended, U.S.$12,429.00 is being offset against the total registration fee due for this Registration Statement. Accordingly, U.S.$22,096 is being paid at the time of filing of this Registration Statement. The Registrants has terminated or completed any offerings that included unsold securities under the Prior Registration Statement.